Intarcia Therapeutics

Overview

Acquisitions: 1 Acquisition
Total Equity Funding: $1.26B in 12 Rounds from 18 Investors
Headquarters: Hayward, California
Description: Intarcia Therapeutics is a biopharmaceutical company developing therapies for diseases that require long-term chronic treatment.
Categories: Medical Device, Health Care, Biotechnology
Website: http://www.intarcia.com

Company Details

Founded: 1997
Contact: busdev@intarcia.com | 617-936-2500
Employees: 251 – 500 | 19 in Crunchbase

Intarcia Therapeutics, Inc. is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. The company’s products includ e OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. The company was formerly known as BioMedicines, Inc. and changed its name to Intarcia Therapeutics, Inc. in September 2004. Intarcia Therapeutics was founded in 1997 and is based in Hayward, California with an additional office in Mountain View, California.